Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis
Public ClinicalTrials.gov record NCT01575834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, International, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if treatment with romosozumab is effective in preventing fractures in women with postmenopausal osteoporosis
Study identification
- NCT ID
- NCT01575834
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 7,180 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years to 90 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2012 (Actual)
- Primary completion
- Dec 14, 2015 (Actual)
- Completion
- Dec 28, 2016 (Actual)
- Last update posted
- Aug 28, 2024
2012 – 2016
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tucson | Arizona | 85704 | — |
| Research Site | Laguna Hills | California | 92653 | — |
| Research Site | Los Angeles | California | 90057 | — |
| Research Site | Sacramento | California | 95817 | — |
| Research Site | Santa Maria | California | 93454 | — |
| Research Site | Walnut Creek | California | 94598 | — |
| Research Site | Lakewood | Colorado | 80227 | — |
| Research Site | Leesburg | Florida | 34748 | — |
| Research Site | Palm Harbor | Florida | 34684 | — |
| Research Site | Plantation | Florida | 33324 | — |
| Research Site | Tampa | Florida | 33614 | — |
| Research Site | Gainesville | Georgia | 30501 | — |
| Research Site | New Orleans | Louisiana | 70121 | — |
| Research Site | Bethesda | Maryland | 20817 | — |
| Research Site | Boston | Massachusetts | 02114 | — |
| Research Site | Detroit | Michigan | 48236 | — |
| Research Site | Albuquerque | New Mexico | 87106 | — |
| Research Site | Asheville | North Carolina | 28803 | — |
| Research Site | Fargo | North Dakota | 58104 | — |
| Research Site | Cincinnati | Ohio | 45236 | — |
| Research Site | Mayfield | Ohio | 44143 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Denton | Texas | 76210-8625 | — |
| Research Site | Richmond | Virginia | 23294 | — |
| Research Site | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 193 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01575834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2024 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01575834 live on ClinicalTrials.gov.